Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo.
Schwab CL, English DP, Black J, Bellone S, Lopez S, Cocco E, Bonazzoli E, Bussi B, Predolini F, Ferrari F, Ratner E, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Santin AD.
Schwab CL, et al.
Gynecol Oncol. 2015 Oct;139(1):112-7. doi: 10.1016/j.ygyno.2015.08.002. Epub 2015 Aug 8.
Gynecol Oncol. 2015.
PMID: 26260909
Free PMC article.